Overnight Trade Opportunity Next Week?!
I'm looking at a BIG Overnight Trade opportunity next week...It's so big...

I'm going to give it to you FREE!

In fact, for the week of October 4-8, you can join our FREE Open House!

You can get ALL our Overnight Trade recommendations, plus ALL of our research and real-time recommendations!
Go Here to Join.
pixel

VRNA Insider Trading (Verona Pharma)

Insider Ownership Percentage: 2.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $120,936.16

Verona Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Verona Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Verona Pharma Share Price & Price History

Current Price: $5.57
Price Change: Price Increase of +0.17 (3.15%)
As of 09/27/2021 05:00 PM ET

This chart shows the closing price history over time for VRNA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
717% Since May 2019?!
Members had the chance to more than 10X their TOTAL PORTFOLIOS by following our recommendations since May 2019...

That's why for one week you can join us as we analyze the market LIVE...

And get all our market intelligence and real-time trading recommendations...

Just RSVP Here (No Cost, No Obligation).
Learn more.
pixel

Verona Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/3/2021David ZaccardelliCEOSell16,000$0.76$12,160.00View SEC Filing Icon  
8/2/2021Mark W HahnCFOSell10,416$0.77$8,020.3216,466,800View SEC Filing Icon  
5/4/2021Anders UllmanDirectorSell12,056$0.84$10,127.04View SEC Filing Icon  
3/1/2021David ZaccardelliCEOSell43,392$1.14$49,466.88View SEC Filing Icon  
3/1/2021Mark W. HahnCFOSell26,728$1.14$30,469.92View SEC Filing Icon  
2/1/2021Anders UllmanDirectorSell10,800$0.99$10,692.00View SEC Filing Icon  
See Full Table
Insider Selling at Verona Pharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Verona Pharma and related companies.

SEC Filings (Institutional Ownership Changes) for Verona Pharma (NASDAQ:VRNA)

61.13% of Verona Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VRNA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Verona Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/11/2021Quantitative Systematic Strategies LLC14,034$92K0.0%-51.9%0.024%Search for SEC Filing on Google Icon
8/11/2021Ghost Tree Capital LLC1,000,000$6.54M1.8%+6.5%1.726%Search for SEC Filing on Google Icon
8/2/2021Chicago Partners Investment Group LLC10,006$58K0.0%N/A0.017%Search for SEC Filing on Google Icon
7/31/2021Wedbush Securities Inc.18,035$0.12M0.0%-18.0%0.031%Search for SEC Filing on Google Icon
5/19/2021venBio Partners LLC161,897$1.35M0.1%-18.7%0.279%Search for SEC Filing on Google Icon
5/17/2021Schonfeld Strategic Advisors LLC56,500$0.47M0.0%+18.2%0.098%Search for SEC Filing on Google Icon
5/17/2021Polar Capital Holdings Plc1,000,000$8.36M0.1%-38.5%1.726%Search for SEC Filing on Google Icon
5/17/2021DAFNA Capital Management LLC18,337$0.15M0.0%-88.6%0.032%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.801,256$6.70M0.5%-22.5%1.383%Search for SEC Filing on Google Icon
5/17/2021Novo Holdings A S838,360$7.01M0.3%-67.9%1.447%Search for SEC Filing on Google Icon
5/14/2021Ghost Tree Capital LLC939,043$7.85M1.8%+15.9%1.621%Search for SEC Filing on Google Icon
5/13/2021Forefront Analytics LLC14,102$0.12M0.1%N/A0.024%Search for SEC Filing on Google Icon
5/7/2021D.A. Davidson & CO.41,900$0.35M0.0%-57.7%0.072%Search for SEC Filing on Google Icon
5/6/2021Quantitative Systematic Strategies LLC29,170$0.24M0.0%N/A0.050%Search for SEC Filing on Google Icon
4/26/2021Wedbush Securities Inc.22,000$0.18M0.0%+83.3%0.038%Search for SEC Filing on Google Icon
4/21/2021Personal CFO Solutions LLC10,000$84K0.0%N/A0.017%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP12,037$84K0.0%N/A0.091%Search for SEC Filing on Google Icon
2/25/2021Hsbc Holdings PLC15,041$0.11M0.0%N/A0.114%Search for SEC Filing on Google Icon
2/18/2021Ghost Tree Capital LLC810,000$5.67M1.2%+0.6%6.152%Search for SEC Filing on Google Icon
2/17/2021IHT Wealth Management LLC18,560$0.13M0.0%-14.7%0.141%Search for SEC Filing on Google Icon
2/16/2021HighVista Strategies LLC26,681$0.19M0.1%N/A0.203%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC24,800$0.17M0.0%N/A0.188%Search for SEC Filing on Google Icon
2/10/2021D.A. Davidson & CO.98,951$0.69M0.0%+13.2%0.752%Search for SEC Filing on Google Icon
11/19/2020Schonfeld Strategic Advisors LLC54,600$0.34M0.0%N/A0.415%Search for SEC Filing on Google Icon
11/17/2020Schonfeld Strategic Advisors LLC54,600$0.34M0.0%N/A0.415%Search for SEC Filing on Google Icon
11/17/2020Polar Capital LLP1,000,000$6.24M0.0%N/A7.595%Search for SEC Filing on Google Icon
11/16/2020Samsara BioCapital LLC1,111,112$6.93M1.9%+2,456.9%8.439%Search for SEC Filing on Google Icon
11/16/2020Perceptive Advisors LLC2,888,889$18.03M0.3%N/A21.942%Search for SEC Filing on Google Icon
11/16/2020Polar Capital LLP1,000,000$6.24M0.0%N/A7.595%Search for SEC Filing on Google Icon
11/16/2020Abingworth LLP2,457,499$15.34M3.3%+172.5%18.665%Search for SEC Filing on Google Icon
11/13/2020Vivo Capital LLC3,048,507$19.02M1.1%+104.2%23.154%Search for SEC Filing on Google Icon
11/13/2020Foresite Capital Management III LLC1,111,112$6.93M5.2%N/A8.439%Search for SEC Filing on Google Icon
11/12/2020Sphera Funds Management LTD.1,000,000$6.24M0.6%N/A7.595%Search for SEC Filing on Google Icon
11/6/2020NEA Management Company LLC5,108,563$31.88M1.3%+318.8%38.801%Search for SEC Filing on Google Icon
11/2/2020D.A. Davidson & CO.87,385$0.55M0.0%-25.2%0.664%Search for SEC Filing on Google Icon
10/20/2020Wedbush Securities Inc.43,300$0.27M0.0%-60.3%0.329%Search for SEC Filing on Google Icon
8/10/2020D.A. Davidson & CO.116,810$0.55M0.0%+34.7%0.887%Search for SEC Filing on Google Icon
7/16/2020Wedbush Securities Inc.109,100$0.51M0.0%+53.8%0.828%Search for SEC Filing on Google Icon
5/18/2020Vivo Capital LLC1,492,951$6.15M0.6%N/A11.339%Search for SEC Filing on Google Icon
5/18/2020venBio Partners LLC456,770$1.88M1.6%-47.8%3.469%Search for SEC Filing on Google Icon
5/14/2020Tekla Capital Management LLC253,179$1.04M0.0%-7.9%1.923%Search for SEC Filing on Google Icon
5/5/2020D.A. Davidson & CO.86,730$0.36M0.0%N/A0.659%Search for SEC Filing on Google Icon
4/23/2020Clear Creek Financial Management LLC37,500$0.17M0.1%N/A0.285%Search for SEC Filing on Google Icon
4/17/2020Wedbush Securities Inc.70,950$0.29M0.0%-12.5%0.539%Search for SEC Filing on Google Icon
2/14/2020UBS Group AG10,055$58K0.0%+801.8%0.076%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC12,500$72K0.0%N/A0.095%Search for SEC Filing on Google Icon
1/16/2020Wedbush Securities Inc.81,100$0.47M0.0%+167.5%0.616%Search for SEC Filing on Google Icon
11/27/2019IHT Wealth Management LLC20,460$94K0.0%+18.1%0.155%Search for SEC Filing on Google Icon
10/17/2019Wedbush Securities Inc.30,315$0.14M0.0%+24.7%0.230%Search for SEC Filing on Google Icon
4/17/2019Wedbush Securities Inc.24,800$0.16M0.0%+75.5%0.189%Search for SEC Filing on Google Icon
2/13/2019Foresite Capital Management III LLC206,663$1.99M0.7%-58.7%1.574%Search for SEC Filing on Google Icon
2/8/2019Aisling Capital Management LP443,596$4.28M4.5%N/A3.378%Search for SEC Filing on Google Icon
1/31/2019Wedbush Securities Inc.14,130$0.13M0.0%N/A0.108%Search for SEC Filing on Google Icon
11/13/2018Foresite Capital Management IV LLC8,302$0.10M0.0%N/A0.063%Search for SEC Filing on Google Icon
5/15/2018Foresite Capital Management III LLC565,292$11.31M2.5%+7.0%4.305%Search for SEC Filing on Google Icon
8/14/2017Tekla Capital Management LLC275,000$3.21M0.1%N/A4.283%Search for SEC Filing on Google Icon
8/11/2017FIL Ltd75,813$0.87M0.0%N/A1.181%Search for SEC Filing on Google Icon
8/2/2017Vivo Capital LLC704,225$8.21M2.1%N/A10.969%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Verona Pharma logo
Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. Its lead product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.
Read More on Verona Pharma

Today's Range

Now: $5.57
Low: $5.42
High: $5.66

50 Day Range

MA: $5.86
Low: $5.29
High: $6.35

52 Week Range

Now: $5.57
Low: $5.08
High: $9.72

Volume

188,462 shs

Average Volume

101,257 shs

Market Capitalization

$334.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.5

Who are the company insiders with the largest holdings of Verona Pharma?

Verona Pharma's top insider shareholders include:
  1. Mark W Hahn (CFO)
  2. Anders Ullman (Director)
  3. David Zaccardelli (CEO)
  4. Mark W Hahn (CFO)
  5. Patrick John Finn (Insider)

Who are the major institutional investors of Verona Pharma?

Verona Pharma's top institutional investors include:
  1. Ghost Tree Capital LLC — 1.73%
  2. Wedbush Securities Inc. — 0.03%
  3. Quantitative Systematic Strategies LLC — 0.02%
  4. Chicago Partners Investment Group LLC — 0.02%
  5. Citadel Advisors LLC — 0.00%

Which major investors are selling Verona Pharma stock?

Within the previous quarter, VRNA stock was sold by these institutional investors:
  1. Quantitative Systematic Strategies LLC
  2. Citadel Advisors LLC
  3. Wedbush Securities Inc.
Within the last year, company insiders that have sold Verona Pharma company stock include:
  1. Mark W Hahn (CFO)
  2. Anders Ullman (Director)
  3. David Zaccardelli (CEO)
  4. Mark W Hahn (CFO)
  5. Patrick John Finn (Insider)

Which major investors are buying Verona Pharma stock?

In the last quarter, VRNA stock was bought by institutional investors including:
  1. Ghost Tree Capital LLC
  2. Chicago Partners Investment Group LLC
Overnight Trade Opportunity Next Week?!
I'm looking at a BIG Overnight Trade opportunity next week...It's so big...

I'm going to give it to you FREE!

In fact, for the week of October 4-8, you can join our FREE Open House!

You can get ALL our Overnight Trade recommendations, plus ALL of our research and real-time recommendations!
Go Here to Join.
pixel